NIPH
IBB icon

NN Investment Partners Holdings’s iShares Biotechnology ETF IBB Stock Holding History

NN Investment Partners Holdings’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$1.4M Buy
10,778
+1,059
+11% +$138K 0.01% 591
2021
Q4 		$1.48M Buy
9,719
+146
+2% +$22.6K 0.01% 594
2021
Q3 		$1.55M Hold
9,573
– – 0.01% 583
2021
Q2 		$1.57M Buy
9,573
+162
+2% +$25K 0.01% 586
2021
Q1 		$1.42M Hold
9,411
– – 0.01% 588
2020
Q4 		$1.43M Hold
9,411
– – 0.01% 597
2020
Q3 		$1.27M Buy
9,411
+762
+9% +$103K 0.01% 559
2020
Q2 		$1.18M Sell
8,649
-2,036
-19% -$260K 0.01% 590
2020
Q1 		$1.15M Hold
10,685
– – 0.01% 552
2019
Q4 		$1.29M Sell
10,685
-599
-5% -$66.8K 0.01% 570
2019
Q3 		$1.12M Hold
11,284
– – 0.01% 578
2019
Q2 		$1.23M Buy
11,284
+502
+5% +$53.4K 0.01% 566
2019
Q1 		$1.21M Buy
10,782
+469
+5% +$51.4K 0.01% 572
2018
Q4 		$994K Sell
10,313
-51
-0.5% -$5.41K 0.01% 552
2018
Q3 		$1.26M Sell
10,364
-491
-5% -$57.8K 0.01% 520
2018
Q2 		$1.19M Buy
10,855
+668
+7% +$71.4K 0.01% 517
2018
Q1 		$1.09M Buy
10,187
+329
+3% +$36.5K 0.01% 534
2017
Q4 		$1.05M Hold
9,858
– – 0.01% 526
2017
Q3 		$1.1M Buy
9,858
+504
+5% +$53.9K 0.01% 556
2017
Q2 		$967K Hold
9,354
– – 0.01% 468
2017
Q1 		$914K Hold
9,354
– – 0.01% 456
2016
Q4 		$827K Buy
9,354
+4,041
+76% +$368K 0.01% 503
2016
Q3 		$513K Sell
5,313
-3,687
-41% -$351K ﹤0.01% 577
2016
Q2 		$772K Hold
9,000
– – 0.01% 514
2016
Q1 		$782K Buy
+9,000
New +$805K 0.01% 511

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

NN Investment Partners Holdings's IBB Position: Q1 2022 in Review

NN Investment Partners Holdings increased its iShares Biotechnology ETF (IBB) stake by 11% in Q1 2022, buying an estimated $138K and bringing the position to 10,778 shares worth $1.4M. The position accounts for 0.01% of the portfolio, ranked #591.

NN Investment Partners Holdings first reported a position in IBB in Q1 2016 and has held it in 25 quarters since. The position peaked at $1.57M in Q2 2021. 897 funds tracked by Wall St. Rank hold IBB as of Q1 2022.

  • NN Investment Partners Holdings held 10,778 shares of iShares Biotechnology ETF worth $1.4M as of Q1 2022.
  • NN Investment Partners Holdings bought 1,059 iShares Biotechnology ETF shares in Q1 2022, an estimated $138K.
  • iShares Biotechnology ETF made up 0.01% of NN Investment Partners Holdings's portfolio in Q1 2022, its #591 holding.
  • NN Investment Partners Holdings first reported a position in iShares Biotechnology ETF in Q1 2016 and has held it in 25 quarters since.
  • NN Investment Partners Holdings's iShares Biotechnology ETF position peaked at $1.57M in Q2 2021.
  • 897 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2022.

Based on NN Investment Partners Holdings's 13F filing for Q1 2022, filed 11 May 2022.